Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
12/1996
12/31/1996US5589458 Compounds that inhibit T cell proliferation and methods for using the same
12/31/1996US5589371 Polypeptides and yeast expression vectors for culture
12/31/1996US5589047 Using dielectrophoresis for genetic engineering
12/31/1996CA2054752C Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine
12/28/1996CA2180029A1 Oxaindene derivatives and process for the preparation thereof
12/27/1996WO1996041807A1 Rapamycin derivatives
12/27/1996WO1996041645A1 Combination of a cyclooxygenase-2 inhibitor and a leukotriene b4 receptor antagonist for the treatment of inflammations
12/27/1996WO1996041626A1 Compositions comprising a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor
12/27/1996WO1996041625A1 Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene a4 hydrolase inhibitor
12/27/1996WO1996041624A1 TNF-α CONVERTING ENZYME
12/27/1996WO1996041618A1 Stable pharmaceutical compositions containing tiludronate hydrates and process for producing the pharmaceutical compositions
12/27/1996EP0749981A1 Monoclonal antibody
12/27/1996EP0749752A1 Use of specific RXR receptor ligands
12/27/1996EP0749494A1 Compositions for the inhibition of tnf formation and uses thereof
12/27/1996EP0749488A1 Anti-il-8 monoclonal antibodies for treatment of inflammatory disorders
12/27/1996EP0749452A1 Polymer-conjugated malonic acid derivatives and their use as medicaments and diagnostic agents
12/27/1996EP0749438A1 Novel silyl compounds and their use
12/27/1996EP0749434A1 Benzothiophene, benzofuran and indolethiazepinones, oxazepinones and diazepinones as inhibitors of cell adhesion and as inhibitors of hiv
12/27/1996EP0749429A1 3,5-disubstituted and 3,5,6-trisubstituted 2-isoxazolines and isoxazoles, process for preparing the same and their use as medicaments
12/27/1996EP0749428A1 Isoxazoline compounds as inhibitors of tnf release
12/27/1996EP0749417A1 Cyano compounds and preparations thereof
12/27/1996EP0749317A1 Therapeutic uses of bactericidal/permeability-increasing protein dimer products
12/27/1996EP0749308A1 Film coated tablet of paracetamol and domperidone
12/27/1996EP0749307A1 Isoxazoline compounds as 5-lipoxygenase inhibitors
12/27/1996EP0749306A1 Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
12/27/1996EP0749302A1 Hydroxamic acid and carboxylic acid derivatives, process for their preparation and use thereof
12/27/1996EP0500853B1 Phenylethanolamines, drugs containing these compounds, and a method of preparing them
12/27/1996CA2224563A1 Combination of a cyclooxygenase-2 inhibitor and a leukotriene b4 receptor antagonist for the treatment of inflammations
12/27/1996CA2224517A1 Compositions comprising a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor
12/27/1996CA2224379A1 Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene a4 hydrolase inhibitor
12/27/1996CA2223568A1 Stable pharmaceutical compositions containing tiludronate hydrates and process for producing the pharmaceutical compositions
12/25/1996CN1138863A Chimeric proteins which block complement activation
12/25/1996CN1138851A Metalloproteinase inhibitors
12/25/1996CN1138583A 9-substituted 2-(2-n-alkoxyphenyl)-purin-6-ones
12/25/1996CN1138474A Antissepsis, antiinflammation and hemostasis capsules
12/24/1996US5587376 Antiischemic agents, decongestants
12/24/1996US5587363 Aminosugar and glycosaminoglycan composition for the treatment and repair of connective tissue
12/20/1996CA2179426A1 Use of ligands specific to rxr receptors
12/19/1996WO1996040923A1 Macrophage derived chemokine and chemokine analogs
12/19/1996WO1996040878A1 Monkey monoclonal antibodies specific to human b7.1 and/or b7.2 primatized forms, pharmaceutical compositions
12/19/1996WO1996040762A1 Monocyte chemotactic protein-4
12/19/1996WO1996040747A1 Urokinase receptor ligands
12/19/1996WO1996040745A2 Amino acid amides of 5-amino-1,3,4-thiadiazones and their use as inhibitors for matrix metalloproteinases
12/19/1996WO1996040737A1 Reversible cysteine protease inhibitors
12/19/1996WO1996040707A1 Water-soluble adenosine kinase inhibitors
12/19/1996WO1996040706A1 Orally active adenosine kinase inhibitors
12/19/1996WO1996040705A1 C-4' modified adenosine kinase inhibitors
12/19/1996WO1996040686A1 Heterocyclic substituted cyclopentane compounds
12/19/1996WO1996040672A1 Combinatorial libraries having aminodiol monomer subunits
12/19/1996WO1996040659A1 N-hydroxyureas as antiinflammatory agents
12/19/1996WO1996040647A1 α-(1,3-DICARBONYLENOL ETHER) METHYL KETONES AS CYSTEINE PROTEASE INHIBITORS
12/19/1996WO1996040639A1 Benzenesulfonamide derivatives used as bradykinine antagonists
12/19/1996WO1996040638A1 Heteroaryl diol acids as leukotriene antagonists
12/19/1996WO1996040260A2 Immunotoxins specific for cd80 and cd86 expressing cells
12/19/1996WO1996040246A1 Treatment of t cell mediated autoimmune disorders
12/19/1996WO1996040232A1 Oral tolerance in skin diseases presenting with t-cell mediated inflammation
12/19/1996WO1996040230A1 Vaccination with peptide of mhc class ii molecules for treatment of autoimmune disease
12/19/1996WO1996040224A1 Regulation of cytokine synthesis and release
12/19/1996WO1996040199A1 Methods of inhibiting phagocytosis
12/19/1996WO1996040194A1 Stable formulations of mhc-peptide complexes
12/19/1996WO1996040186A1 Relaxin-like factor and methods and uses thereof
12/19/1996WO1996040169A1 Bacterial inhibition with an oligosaccharide compound
12/19/1996WO1996040161A1 Ether derivatives of pseudopterosin
12/19/1996WO1996040143A1 Imidazole compounds
12/19/1996WO1996040123A1 Antigen-processing cell-targeted conjugates
12/19/1996WO1996040118A1 Thrombin inhibitors
12/19/1996WO1996040117A1 Methods of treating microbial infections
12/19/1996WO1996040116A1 Indolinone compounds for the treatment of disease
12/19/1996WO1996040103A1 Treatment of a trabecular meshwork whose cells are subject ot inhibition of cell division with non-steroidal anti-inflammatory drugs
12/19/1996WO1996040102A1 Non-steroidal anti-inflammatory drugs for the cyto-protection of the trabecular meshwork
12/19/1996WO1996040100A1 ARYLSULFONYLAMINOBENZENE DERIVATIVES AND THE USE THEREOF AS FACTOR Xa INHIBITORS
12/19/1996WO1996040078A1 Delivery of drugs to the lower gi tract
12/19/1996WO1996039831A1 Prodrugs of pharmaceuticals with improved bioavailability
12/19/1996CA2247984A1 Orally active adenosine kinase inhibitors
12/19/1996CA2247983A1 Water-soluble adenosine kinase inhibitors
12/19/1996CA2224170A1 Delivery of drugs to the lower gi tract
12/19/1996CA2224113A1 Amino acid amides of 5-amino-1,3,4-thiadiazones and their use as inhibitors for matrix metalloproteinases
12/19/1996CA2224102A1 Bacterial inhibition with an oligosaccharide compound
12/19/1996CA2224099A1 Monocyte chemotactic protein-4
12/19/1996CA2223727A1 Arylsulfonylaminobenzene derivatives and the use thereof as factor xa inhibitors
12/19/1996CA2223714A1 Vaccination with peptide of mhc class ii molecules for treatment of autoimmune disease
12/19/1996CA2223605A1 Stable formulations of mhc-peptide complexes
12/19/1996CA2223533A1 Imidazole compounds
12/19/1996CA2223500A1 Thrombin inhibitors
12/19/1996CA2223303A1 Treatment of t cell mediated autoimmune disorders
12/19/1996CA2223268A1 .alpha.-(1,3-dicarbonylenol ether) methyl ketones as cysteine protease inhibitors
12/19/1996CA2222972A1 Reversible cysteine protease inhibitors
12/19/1996CA2222930A1 Treatment of a trabecular meshwork whose cells are subject to inhibition of cell division with non-steroidal anti-inflammatory drugs
12/19/1996CA2222929A1 Non-steroidal anti-inflammatory drugs for the cyto-protection of the trabecular meshwork
12/19/1996CA2222247A1 Immunotoxins specific for cd80 and cd86 expressing cells
12/19/1996CA2221601A1 Regulation of cytokine synthesis and release
12/19/1996CA2220642A1 C-4' modified adenosine kinase inhibitors
12/19/1996CA2220006A1 Heterocyclic substituted cyclopentane compounds
12/19/1996CA2219457A1 Oral tolerance in skin diseases presenting with t-cell mediated inflammation
12/19/1996CA2196691A1 Macrophage derived chemokine and chemokine analogs
12/19/1996CA2196334A1 Urokinase receptor ligands
12/18/1996EP0748816A1 Toxoplasma gondii antigen, its production and use
12/18/1996EP0748815A1 Toxoplasma gondii antigen, its production and use
12/18/1996EP0748628A2 Oral formulations of S(+)-Etodolac
12/18/1996EP0748320A1 Prodrugs of morpholine tachykinin receptor antagonists
1 ... 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 1163 1164 1165 1166 ... 1272